drugset / Trial / NCT05844930
A Study to Determine the Safety and Effectiveness of a Connective Tissue Allograft (ActiveMatrix) Verses Standard of Care in Adhesive Capsulitis of the Shoulder
Phase 4
Completed
56 enrolled
The University of Texas Health Science Center, Houston
Skye Biologics Holdings, LLC · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to compare ActiveMatrix® to standard of care corticosteroid injection in the treatment of adhesive capsulitis of the shoulder (frozen shoulder).
Timeline
- Start
- 2023-01-03
- Primary completion
- 2025-02-04
- Completion
- 2025-02-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ActiveMatrix | Other / unclassified | 1 ml | Other |
| Subject | Triamcinolone | Other / unclassified | 20 mg | Other |
| Background | Lidocaine | Other / unclassified | 10 mg/ml | Other |